You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

GLEOSTINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Gleostine, and what generic alternatives are available?

Gleostine is a drug marketed by Latina Pharma and is included in one NDA.

The generic ingredient in GLEOSTINE is lomustine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lomustine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GLEOSTINE?
  • What are the global sales for GLEOSTINE?
  • What is Average Wholesale Price for GLEOSTINE?
Summary for GLEOSTINE
Drug patent expirations by year for GLEOSTINE
Drug Prices for GLEOSTINE

See drug prices for GLEOSTINE

Recent Clinical Trials for GLEOSTINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 3
NRG OncologyPhase 3
Emory UniversityEarly Phase 1

See all GLEOSTINE clinical trials

Pharmacology for GLEOSTINE
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

US Patents and Regulatory Information for GLEOSTINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Latina Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-004 Dec 19, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Latina Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-003 Approved Prior to Jan 1, 1982 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Latina Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Latina Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-002 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.